Ownership history in Prosight Management, LP · 11 quarters on record
This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 743,942 | -524,023 | -41.3% | 0.54% | $2.6M | $3.51 |
| 2025 Q3 | REDUCED | 1,267,965 | -312,623 | -19.8% | 0.96% | $4.1M | $3.26 |
| 2025 Q2 | ADDED | 1,580,588 | +100,588 | +6.8% | 0.94% | $3.9M | $2.45 |
| 2025 Q1 | ADDED | 1,480,000 | +391,294 | +35.9% | 3.24% | $9.9M | $6.67 |
| 2024 Q4 | ADDED | 1,088,706 | +929,337 | +583.1% | 3.78% | $13.7M | $12.57 |
| 2024 Q3 | ADDED | 159,369 | +127,176 | +395.0% | 0.72% | $2.9M | $18.47 |
| 2022 Q4 | REDUCED | 32,193 | -167,807 | -83.9% | 0.34% | $630K | $19.57 |
| 2022 Q3 | REDUCED | 200,000 | -76,802 | -27.7% | 1.71% | $3.2M | $15.96 |
| 2022 Q2 | ADDED | 276,802 | +73,534 | +36.2% | 3.00% | $3.8M | $13.76 |
| 2022 Q1 | ADDED | 203,268 | +74,563 | +57.9% | 2.08% | $3.2M | $15.86 |
As of 2025 Q4 — sorted by position size